Streetbeat News

Products Services

PMN

ProMIS Neurosciences Inc. (NASDAQ:PMN) shares surged after the company presented preclinical data supporting the potential therapeutic advantage of its lead candidate for Alzheimer's disease, PMN310, at AAIC 2023. The company also received clearance from the FDA for its Investigational New Drug (IND) application for PMN310. Shares of PMN were up 113.5% at $6.00 at the time of publication.

Portfolio Pulse from Ryan Gustafson

July 17, 2023 | 6:22 pm

LLY

Eli Lilly has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that its Alzheimer's drug candidate, donanemab, significantly slowed cognitive and functional decline in early symptomatic Alzheimer's patients. The submission to the FDA for traditional approval was completed last quarter, with regulatory action expected by the end of the year.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 6:05 pm

TSLA

Tesla plans to double the size of its factory near Berlin, aiming to produce up to one million electric cars a year. This could make it the largest auto manufacturing facility in Germany. The company has applied for approval to expand its existing factory in Brandenburg to increase production capacity for vehicles and batteries. Tesla's Model Y and Model 3 were the bestselling all-electric vehicles in Europe in the first quarter, outpacing Volkswagen's ID.3 and ID.4. However, the expansion plan could face resistance due to environmental concerns.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 6:03 pm

APLS

Apellis Pharmaceuticals Inc's shares are trading lower due to safety concerns about its newly launched product, Syfovre. The ASRS Research and Safety in Therapeutics Committee reported six cases of occlusive retinal vasculitis since the product's launch in March. Despite this, the company has distributed approximately 60,000 vials of Syfovre since its FDA approval, exceeding the Street-high 2Q23 estimate by about 15,000 vials. This could imply a 2Q23 Syfovre revenue of over $80 million.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 5:59 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) announced that its cloud-based design and proposal software platform, Solargraf, is now available in Brazil. The company also received a price target change from Morgan Stanley analyst Andrew Percoco, who maintained an Equal-Weight rating but lowered the price target from $268 to $234. Shares of ENPH were up 5.95% at the time of publication.

Portfolio Pulse from Ryan Gustafson

July 17, 2023 | 5:58 pm

PLTR

Shares of Palantir Technologies Inc (NYSE:PLTR) are trading higher, adding to gains of over 95% in the last three months. The rally is driven by optimism surrounding the future of AI, with Palantir reporting strong demand for its new AI platform. The company's shares accelerated in May after better-than-expected quarterly results and guidance for continued profitability in 2023. Palantir's CEO reiterated the high demand for its AI products at the company's first AIPCon in June.

Portfolio Pulse from Adam Eckert

July 17, 2023 | 5:42 pm

MULN

Mullen Automotive Inc's shares are rising after the company received a 30-unit purchase order for the Mullen-GO Commercial Urban Delivery EV from Newgate Motor Group, valued at $321K. The transaction will be reflected in Mullen's current fiscal quarter reporting. Newgate and Mullen have plans for up to 500 vehicles per year. Last week, Mullen launched a new EV pilot program in upstate New York.

Portfolio Pulse from Lekha Gupta

July 17, 2023 | 5:13 pm

ARQT

Arcutis Biotherapeutics announced that its ZORYBE cream 0.3% for plaque psoriasis is now a preferred tier product on CVS Caremark's largest national commercial formularies. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 4:59 pm

UBSFF

Ubisoft Entertainment SA (OTC:UBSFF) and Spanish gaming company OWO have collaborated to create a haptic feedback vest for the game Assassin's Creed Mirage. The vest, which is compatible with PC, PS5, and Xbox Series X|S versions of the game, allows players to feel every move, punch, and parkour leap in the game. The system is wireless and has a battery life of around eight hours. The vest is not yet available for pre-order and its price has not been revealed.

Portfolio Pulse from Franca Quarneti

July 17, 2023 | 4:44 pm

AZN

The FDA has approved AstraZeneca's Beyfortus for the prevention of Respiratory Syncytial Virus in babies and toddlers. This approval could potentially increase AstraZeneca's market share in the pharmaceutical industry.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 4:43 pm